News and Updates
Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease
Jan 16, 2023 // Study Updates
The OHS contributed genotyping data from 7,300 consented participants to a groundbreaking global initiative to research the underlying biology of human disease and disease traits. As the largest contributor to CanPath, the OHS is the only Canadian study to be included in the Global Biobank Meta-analysis Initiative (GBMI), which to date involves genetic data from 2.2
Smoking history associated with decreased heart inflammation in Clinically Manifest Cardiac Sarcoidosis patients
Nov 24, 2022 // Study Updates
The causes of sarcoidosis, an inflammatory disease diagnosed in an estimated 21,000 Canadians, remain unknown. A specific form affecting the heart, cardiac sarcoidosis (or CS), is considered especially serious, being responsible for roughly 85% of deaths from the disease despite accounting for only 5% of sarcoidosis cases. A group of researchers led by Dr. David
OHS profiled in the International Journal of Epidemiology
Aug 15, 2022 // Study Updates
Cohort profile papers are important markers for studies like the OHS, because they outline the history and value of their research platforms for the broader scientific community, thus encouraging further use by other scientists. The International Journal of Epidemiology published a profile of the Ontario Health Study in its September 2022 issue. The OHS follows
New funding available for research using OHS data
Aug 8, 2022 // Study Updates
A new funding opportunity from the CIHR Institute of Cancer Research (CIHR-ICR) is available and provides up to $500,000 to use provincial data from the OHS, or to use pan-Canadian data from the Canadian Partnership for Tomorrow’s Health (CanPath). Up to $100,000 over one year will be awarded for a single grant. The goal of
